PharmacyCodes



N-[1-(4-Bromophenyl)Ethyl]-5-Fluoro Salicylamide en es it fr

Categoria

N-[1-(4-Bromophenyl)Ethyl]-5-Fluoro Salicylamide Nombres de marca, N-[1-(4-Bromophenyl)Ethyl]-5-Fluoro Salicylamide Analogos

N-[1-(4-Bromophenyl)Ethyl]-5-Fluoro Salicylamide Marca los nombres de mezcla

N-[1-(4-Bromophenyl)Ethyl]-5-Fluoro Salicylamide Formula quimica

N-[1-(4-Bromophenyl)Ethyl]-5-Fluoro Salicylamide RX enlace

N-[1-(4-Bromophenyl)Ethyl]-5-Fluoro Salicylamide FDA hoja

N-[1-(4-Bromophenyl)Ethyl]-5-Fluoro Salicylamide MSDS (hoja de seguridad de materiales)

N-[1-(4-Bromophenyl)Ethyl]-5-Fluoro Salicylamide Sintesis de referencia

N-[1-(4-Bromophenyl)Ethyl]-5-Fluoro Salicylamide Peso molecular

N-[1-(4-Bromophenyl)Ethyl]-5-Fluoro Salicylamide Punto de fusion

N-[1-(4-Bromophenyl)Ethyl]-5-Fluoro Salicylamide H2O Solubilidad

N-[1-(4-Bromophenyl)Ethyl]-5-Fluoro Salicylamide Estado

N-[1-(4-Bromophenyl)Ethyl]-5-Fluoro Salicylamide LogP

N-[1-(4-Bromophenyl)Ethyl]-5-Fluoro Salicylamide Formas de dosificacion

N-[1-(4-Bromophenyl)Ethyl]-5-Fluoro Salicylamide Indicacion

N-[1-(4-Bromophenyl)Ethyl]-5-Fluoro Salicylamide Farmacologia

N-[1-(4-Bromophenyl)Ethyl]-5-Fluoro Salicylamide Absorcion

N-[1-(4-Bromophenyl)Ethyl]-5-Fluoro Salicylamide Toxicidad

N-[1-(4-Bromophenyl)Ethyl]-5-Fluoro Salicylamide Informacion de Pacientes

N-[1-(4-Bromophenyl)Ethyl]-5-Fluoro Salicylamide Organismos afectados